<DOC>
	<DOCNO>NCT01440881</DOCNO>
	<brief_summary>This project evaluate whether nesiritide , human recombinant brain natriuretic peptide , confers renal protection cardiovascular surgery attenuate inflammatory response .</brief_summary>
	<brief_title>Does Nesiritide Provide Renal Protection</brief_title>
	<detailed_description>This randomize , prospective blind pilot study compare nesiritide placebo patient undergoing aortic arch , ascend aorta , aortic valve mitral valve surgery baseline GFR 30-90ml/min . Patients randomize either placebo nesiritide ( administer prophylactically start operating room prior incision 0.01 mcg/kg /minute bolus continue 48 hour ) .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Natriuretic Peptide , Brain</mesh_term>
	<criteria>Patients undergo surgery aortic arch , ascend aorta , aortic valve mitral valve surgery Baseline MDRD ( modification diet renal disease ) calculate GFR ( Glomerular Filtration Rate ) 3090 ml/min . Signed Informed Consent Age &lt; 18 &gt; 80 Ejection Fraction &lt; 30 % . Presence endocarditis infection . Presence anticipate use intraaortic balloon pump . History organ transplant . History adverse reaction nesiritide . Surgery perform without cardiopulmonary bypass . Receiving Aprotinin Dopamine administer dos &lt; 5 mcg /kg min . Women child bear potential pregnant breastfeeding . Participation investigational trial Jehovah Witness Bleeding Disorder Active Endocarditis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>renal failure</keyword>
	<keyword>cardiopulmonary bypass</keyword>
</DOC>